APO Research
Talk to an analyst

APO RESEARCH · REPORT

OTC Probiotics Supplement

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global OTC Probiotics Supplement Market Outlook and Growth Opportunities 2026

2 January 2026192 pages

Choose your research edition.

Industry ResearchOTC Probiotics Supplement Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal OTC Probiotics Supplement Industry Growth and Trends Forecast to 203287 pages · $3,450 USDMarket StructureGlobal OTC Probiotics Supplement Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032186 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal OTC Probiotics Supplement Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal OTC Probiotics Supplement Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global OTC Probiotics Supplement market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for OTC Probiotics Supplement is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for OTC Probiotics Supplement is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for OTC Probiotics Supplement is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the OTC Probiotics Supplement market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the OTC Probiotics Supplement market include Danone, Dietary Pros, Inc., DuPont, Kibow Biotech, Lifeway Foods, Inc., Osmotica Pharmaceuticals Corp, Pharmavite LLC, Probi AB and Royal DSM, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global OTC Probiotics Supplement market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of OTC Probiotics Supplement and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents OTC Probiotics Supplement revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global OTC Probiotics Supplement market.

OTC Probiotics Supplement Segment by Company

Danone

Dietary Pros, Inc.

DuPont

Kibow Biotech

Lifeway Foods, Inc.

Osmotica Pharmaceuticals Corp

Pharmavite LLC

Probi AB

Royal DSM

OTC Probiotics Supplement Segment by Type

Capsules

Powder

Syrups

OTC Probiotics Supplement Segment by Application

Online

Offline

OTC Probiotics Supplement Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global OTC Probiotics Supplement status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the OTC Probiotics Supplement key companies, revenue, market share, and recent developments.

3. To split the OTC Probiotics Supplement breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions OTC Probiotics Supplement market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify OTC Probiotics Supplement significant trends, drivers, influence factors in global and regions.

6. To analyze OTC Probiotics Supplement competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global OTC Probiotics Supplement market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of OTC Probiotics Supplement and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of OTC Probiotics Supplement.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global OTC Probiotics Supplement industry.

Chapter 3: Detailed analysis of OTC Probiotics Supplement company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of OTC Probiotics Supplement in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of OTC Probiotics Supplement in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. OTC Probiotics Supplement Industry Trends Table 2. OTC Probiotics Supplement Industry Drivers Table 3. OTC Probiotics Supplement Industry Opportunities and Challenges Table 4. OTC Probiotics Supplement Industry Restraints Table 5. Global OTC Probiotics Supplement Revenue by Company (US$ Million) & (2021-2026) Table 6. Global OTC Probiotics Supplement Revenue Share by Company (2021-2026) Table 7. Global OTC Probiotics Supplement Company Ranking, (2024-2026) & (US$ Million) Table 8. Global OTC Probiotics Supplement Key Company Manufacturing Base & Headquarters Table 9. Global OTC Probiotics Supplement Company, Product Type & Application Table 10. Global OTC Probiotics Supplement Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global OTC Probiotics Supplement by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Capsules Table 15. Significant Companies of Powder Table 16. Significant Companies of Syrups Table 17. Global OTC Probiotics Supplement Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 18. Global OTC Probiotics Supplement Sales Value by Type (2021-2026) & (US$ Million) Table 19. Global OTC Probiotics Supplement Sales Value by Type (2027-2032) & (US$ Million) Table 20. Global OTC Probiotics Supplement Sales Value Share by Type (2021-2026) Table 21. Global OTC Probiotics Supplement Sales Value Share by Type (2027-2032) Table 22. Significant Companies of Online Table 23. Significant Companies of Offline Table 24. Global OTC Probiotics Supplement Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global OTC Probiotics Supplement Sales Value by Application (2021-2026) & (US$ Million) Table 26. Global OTC Probiotics Supplement Sales Value by Application (2027-2032) & (US$ Million) Table 27. Global OTC Probiotics Supplement Sales Value Share by Application (2021-2026) Table 28. Global OTC Probiotics Supplement Sales Value Share by Application (2027-2032) Table 29. Global OTC Probiotics Supplement Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global OTC Probiotics Supplement Sales Value by Region (2021-2026) & (US$ Million) Table 31. Global OTC Probiotics Supplement Sales Value Share by Region (2021-2026) Table 32. Global OTC Probiotics Supplement Sales Value by Region (2027-2032) & (US$ Million) Table 33. Global OTC Probiotics Supplement Sales Value Share by Region (2027-2032) Table 34. Global OTC Probiotics Supplement Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global OTC Probiotics Supplement Sales Value by Country (2021-2026) & (US$ Million) Table 36. Global OTC Probiotics Supplement Sales Value Market Share by Country (2021-2026) Table 37. Global OTC Probiotics Supplement Sales Value by Country (2027-2032) & (US$ Million) Table 38. Global OTC Probiotics Supplement Sales Value Market Share by Country (2027-2032) Table 39. Danone Company Information Table 40. Danone Business Overview Table 41. Danone OTC Probiotics Supplement Revenue (US$ Million) and Gross Margin (2021-2026) Table 42. Danone OTC Probiotics Supplement Product Portfolio Table 43. Danone Recent Development Table 44. Dietary Pros, Inc. Company Information Table 45. Dietary Pros, Inc. Business Overview Table 46. Dietary Pros, Inc. OTC Probiotics Supplement Revenue (US$ Million) and Gross Margin (2021-2026) Table 47. Dietary Pros, Inc. OTC Probiotics Supplement Product Portfolio Table 48. Dietary Pros, Inc. Recent Development Table 49. DuPont Company Information Table 50. DuPont Business Overview Table 51. DuPont OTC Probiotics Supplement Revenue (US$ Million) and Gross Margin (2021-2026) Table 52. DuPont OTC Probiotics Supplement Product Portfolio Table 53. DuPont Recent Development Table 54. Kibow Biotech Company Information Table 55. Kibow Biotech Business Overview Table 56. Kibow Biotech OTC Probiotics Supplement Revenue (US$ Million) and Gross Margin (2021-2026) Table 57. Kibow Biotech OTC Probiotics Supplement Product Portfolio Table 58. Kibow Biotech Recent Development Table 59. Lifeway Foods, Inc. Company Information Table 60. Lifeway Foods, Inc. Business Overview Table 61. Lifeway Foods, Inc. OTC Probiotics Supplement Revenue (US$ Million) and Gross Margin (2021-2026) Table 62. Lifeway Foods, Inc. OTC Probiotics Supplement Product Portfolio Table 63. Lifeway Foods, Inc. Recent Development Table 64. Osmotica Pharmaceuticals Corp Company Information Table 65. Osmotica Pharmaceuticals Corp Business Overview Table 66. Osmotica Pharmaceuticals Corp OTC Probiotics Supplement Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Osmotica Pharmaceuticals Corp OTC Probiotics Supplement Product Portfolio Table 68. Osmotica Pharmaceuticals Corp Recent Development Table 69. Pharmavite LLC Company Information Table 70. Pharmavite LLC Business Overview Table 71. Pharmavite LLC OTC Probiotics Supplement Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Pharmavite LLC OTC Probiotics Supplement Product Portfolio Table 73. Pharmavite LLC Recent Development Table 74. Probi AB Company Information Table 75. Probi AB Business Overview Table 76. Probi AB OTC Probiotics Supplement Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Probi AB OTC Probiotics Supplement Product Portfolio Table 78. Probi AB Recent Development Table 79. Royal DSM Company Information Table 80. Royal DSM Business Overview Table 81. Royal DSM OTC Probiotics Supplement Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Royal DSM OTC Probiotics Supplement Product Portfolio Table 83. Royal DSM Recent Development Table 84. Research Programs/Design for This Report Table 85. Authors List of This Report Table 86. Secondary Sources Table 87. Primary Sources List of Figures Figure 1. OTC Probiotics Supplement Product Image Figure 2. Global OTC Probiotics Supplement Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global OTC Probiotics Supplement Market Size (2021-2032) & (US$ Million) Figure 4. Global OTC Probiotics Supplement Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Capsules Image Figure 8. Powder Image Figure 9. Syrups Image Figure 10. Global OTC Probiotics Supplement Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 11. Global OTC Probiotics Supplement Sales Value Share 2021 VS 2025 VS 2032 Figure 12. Global OTC Probiotics Supplement Sales Value Share by Type (2021-2032) Figure 13. Online Image Figure 14. Offline Image Figure 15. Global OTC Probiotics Supplement Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global OTC Probiotics Supplement Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global OTC Probiotics Supplement Sales Value Share by Application (2021-2032) Figure 18. Global OTC Probiotics Supplement Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 19. Global OTC Probiotics Supplement Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 20. North America OTC Probiotics Supplement Sales Value (2021-2032) & (US$ Million) Figure 21. North America OTC Probiotics Supplement Sales Value Share by Country (%), 2025 VS 2032 Figure 22. Europe OTC Probiotics Supplement Sales Value (2021-2032) & (US$ Million) Figure 23. Europe OTC Probiotics Supplement Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Asia-Pacific OTC Probiotics Supplement Sales Value (2021-2032) & (US$ Million) Figure 25. Asia-Pacific OTC Probiotics Supplement Sales Value Share by Country (%), 2025 VS 2032 Figure 26. South America OTC Probiotics Supplement Sales Value (2021-2032) & (US$ Million) Figure 27. South America OTC Probiotics Supplement Sales Value Share by Country (%), 2025 VS 2032 Figure 28. Middle East & Africa OTC Probiotics Supplement Sales Value (2021-2032) & (US$ Million) Figure 29. Middle East & Africa OTC Probiotics Supplement Sales Value Share by Country (%), 2025 VS 2032 Figure 30. USA OTC Probiotics Supplement Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 31. USA OTC Probiotics Supplement Sales Value Share by Type, 2025 VS 2032 & (%) Figure 32. USA OTC Probiotics Supplement Sales Value Share by Application, 2025 VS 2032 & (%) Figure 33. Canada OTC Probiotics Supplement Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 34. Canada OTC Probiotics Supplement Sales Value Share by Type, 2025 VS 2032 & (%) Figure 35. Canada OTC Probiotics Supplement Sales Value Share by Application, 2025 VS 2032 & (%) Figure 36. Mexico OTC Probiotics Supplement Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 37. Mexico OTC Probiotics Supplement Sales Value Share by Type, 2025 VS 2032 & (%) Figure 38. Mexico OTC Probiotics Supplement Sales Value Share by Application, 2025 VS 2032 & (%) Figure 39. Germany OTC Probiotics Supplement Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. Germany OTC Probiotics Supplement Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. Germany OTC Probiotics Supplement Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. France OTC Probiotics Supplement Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. France OTC Probiotics Supplement Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. France OTC Probiotics Supplement Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. U.K. OTC Probiotics Supplement Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. U.K. OTC Probiotics Supplement Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. U.K. OTC Probiotics Supplement Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Italy OTC Probiotics Supplement Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Italy OTC Probiotics Supplement Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Italy OTC Probiotics Supplement Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Spain OTC Probiotics Supplement Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Spain OTC Probiotics Supplement Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Spain OTC Probiotics Supplement Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Russia OTC Probiotics Supplement Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Russia OTC Probiotics Supplement Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Russia OTC Probiotics Supplement Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Netherlands OTC Probiotics Supplement Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Netherlands OTC Probiotics Supplement Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Netherlands OTC Probiotics Supplement Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Nordic Countries OTC Probiotics Supplement Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Nordic Countries OTC Probiotics Supplement Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Nordic Countries OTC Probiotics Supplement Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. China OTC Probiotics Supplement Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. China OTC Probiotics Supplement Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. China OTC Probiotics Supplement Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Japan OTC Probiotics Supplement Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Japan OTC Probiotics Supplement Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Japan OTC Probiotics Supplement Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. South Korea OTC Probiotics Supplement Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. South Korea OTC Probiotics Supplement Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. South Korea OTC Probiotics Supplement Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. India OTC Probiotics Supplement Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. India OTC Probiotics Supplement Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. India OTC Probiotics Supplement Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Australia OTC Probiotics Supplement Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Australia OTC Probiotics Supplement Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Australia OTC Probiotics Supplement Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Southeast Asia OTC Probiotics Supplement Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Southeast Asia OTC Probiotics Supplement Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Southeast Asia OTC Probiotics Supplement Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Brazil OTC Probiotics Supplement Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Brazil OTC Probiotics Supplement Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Brazil OTC Probiotics Supplement Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Argentina OTC Probiotics Supplement Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Argentina OTC Probiotics Supplement Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Argentina OTC Probiotics Supplement Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Chile OTC Probiotics Supplement Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Chile OTC Probiotics Supplement Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Chile OTC Probiotics Supplement Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Colombia OTC Probiotics Supplement Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Colombia OTC Probiotics Supplement Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Colombia OTC Probiotics Supplement Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Peru OTC Probiotics Supplement Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Peru OTC Probiotics Supplement Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Peru OTC Probiotics Supplement Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Saudi Arabia OTC Probiotics Supplement Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Saudi Arabia OTC Probiotics Supplement Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Saudi Arabia OTC Probiotics Supplement Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Israel OTC Probiotics Supplement Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Israel OTC Probiotics Supplement Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Israel OTC Probiotics Supplement Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. UAE OTC Probiotics Supplement Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. UAE OTC Probiotics Supplement Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. UAE OTC Probiotics Supplement Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Turkey OTC Probiotics Supplement Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Turkey OTC Probiotics Supplement Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Turkey OTC Probiotics Supplement Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Iran OTC Probiotics Supplement Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Iran OTC Probiotics Supplement Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Iran OTC Probiotics Supplement Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Egypt OTC Probiotics Supplement Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Egypt OTC Probiotics Supplement Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Egypt OTC Probiotics Supplement Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Years Considered Figure 115. Research Process Figure 116. Key Executives Interviewed

Scope & coverage.

Types
  • Capsules
  • Powder
  • Syrups
Applications
  • Online
  • Offline
Companies covered
  • Danone
  • Dietary Pros, Inc.
  • DuPont
  • Kibow Biotech
  • Lifeway Foods, Inc.
  • Osmotica Pharmaceuticals Corp
  • Pharmavite LLC
  • Probi AB
  • Royal DSM

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global OTC Probiotics Supplement Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global OTC Probiotics Supplement Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 OTC Probiotics Supplement Market Dynamics
  1. 2.1 OTC Probiotics Supplement Industry Trends
  2. 2.2 OTC Probiotics Supplement Industry Drivers
  3. 2.3 OTC Probiotics Supplement Industry Opportunities and Challenges
  4. 2.4 OTC Probiotics Supplement Industry Restraints
3 OTC Probiotics Supplement Market by Company
  1. 3.1 Global OTC Probiotics Supplement Company Revenue Ranking in 2025
  2. 3.2 Global OTC Probiotics Supplement Revenue by Company (2021-2026)
  3. 3.3 Global OTC Probiotics Supplement Company Ranking (2024-2026)
  4. 3.4 Global OTC Probiotics Supplement Company Manufacturing Base and Headquarters
  5. 3.5 Global OTC Probiotics Supplement Company Product Type and Application
  6. 3.6 Global OTC Probiotics Supplement Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global OTC Probiotics Supplement Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 OTC Probiotics Supplement Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 OTC Probiotics Supplement Market by Type
  1. 4.1 OTC Probiotics Supplement Type Introduction
  2. 4.1.1 Capsules
  3. 4.1.2 Powder
  4. 4.1.3 Syrups
  5. 4.2 Global OTC Probiotics Supplement Sales Value by Type
  6. 4.2.1 Global OTC Probiotics Supplement Sales Value by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global OTC Probiotics Supplement Sales Value by Type (2021-2032)
  8. 4.2.3 Global OTC Probiotics Supplement Sales Value Share by Type (2021-2032)
5 OTC Probiotics Supplement Market by Application
  1. 5.1 OTC Probiotics Supplement Application Introduction
  2. 5.1.1 Online
  3. 5.1.2 Offline
  4. 5.2 Global OTC Probiotics Supplement Sales Value by Application
  5. 5.2.1 Global OTC Probiotics Supplement Sales Value by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global OTC Probiotics Supplement Sales Value by Application (2021-2032)
  7. 5.2.3 Global OTC Probiotics Supplement Sales Value Share by Application (2021-2032)
6 OTC Probiotics Supplement Regional Value Analysis
  1. 6.1 Global OTC Probiotics Supplement Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global OTC Probiotics Supplement Sales Value by Region (2021-2032)
  3. 6.2.1 Global OTC Probiotics Supplement Sales Value by Region: 2021-2026
  4. 6.2.2 Global OTC Probiotics Supplement Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America OTC Probiotics Supplement Sales Value (2021-2032)
  7. 6.3.2 North America OTC Probiotics Supplement Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe OTC Probiotics Supplement Sales Value (2021-2032)
  10. 6.4.2 Europe OTC Probiotics Supplement Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific OTC Probiotics Supplement Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific OTC Probiotics Supplement Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America OTC Probiotics Supplement Sales Value (2021-2032)
  16. 6.6.2 South America OTC Probiotics Supplement Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa OTC Probiotics Supplement Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa OTC Probiotics Supplement Sales Value Share by Country, 2025 VS 2032
7 OTC Probiotics Supplement Country-level Value Analysis
  1. 7.1 Global OTC Probiotics Supplement Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global OTC Probiotics Supplement Sales Value by Country (2021-2032)
  3. 7.2.1 Global OTC Probiotics Supplement Sales Value by Country (2021-2026)
  4. 7.2.2 Global OTC Probiotics Supplement Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA OTC Probiotics Supplement Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA OTC Probiotics Supplement Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA OTC Probiotics Supplement Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada OTC Probiotics Supplement Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada OTC Probiotics Supplement Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada OTC Probiotics Supplement Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico OTC Probiotics Supplement Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico OTC Probiotics Supplement Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico OTC Probiotics Supplement Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany OTC Probiotics Supplement Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany OTC Probiotics Supplement Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany OTC Probiotics Supplement Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France OTC Probiotics Supplement Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France OTC Probiotics Supplement Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France OTC Probiotics Supplement Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. OTC Probiotics Supplement Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. OTC Probiotics Supplement Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. OTC Probiotics Supplement Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy OTC Probiotics Supplement Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy OTC Probiotics Supplement Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy OTC Probiotics Supplement Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain OTC Probiotics Supplement Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain OTC Probiotics Supplement Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain OTC Probiotics Supplement Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia OTC Probiotics Supplement Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia OTC Probiotics Supplement Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia OTC Probiotics Supplement Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands OTC Probiotics Supplement Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands OTC Probiotics Supplement Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands OTC Probiotics Supplement Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries OTC Probiotics Supplement Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries OTC Probiotics Supplement Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries OTC Probiotics Supplement Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China OTC Probiotics Supplement Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China OTC Probiotics Supplement Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China OTC Probiotics Supplement Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan OTC Probiotics Supplement Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan OTC Probiotics Supplement Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan OTC Probiotics Supplement Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea OTC Probiotics Supplement Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea OTC Probiotics Supplement Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea OTC Probiotics Supplement Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India OTC Probiotics Supplement Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India OTC Probiotics Supplement Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India OTC Probiotics Supplement Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia OTC Probiotics Supplement Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia OTC Probiotics Supplement Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia OTC Probiotics Supplement Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia OTC Probiotics Supplement Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia OTC Probiotics Supplement Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia OTC Probiotics Supplement Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil OTC Probiotics Supplement Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil OTC Probiotics Supplement Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil OTC Probiotics Supplement Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina OTC Probiotics Supplement Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina OTC Probiotics Supplement Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina OTC Probiotics Supplement Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile OTC Probiotics Supplement Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile OTC Probiotics Supplement Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile OTC Probiotics Supplement Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia OTC Probiotics Supplement Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia OTC Probiotics Supplement Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia OTC Probiotics Supplement Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru OTC Probiotics Supplement Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru OTC Probiotics Supplement Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru OTC Probiotics Supplement Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia OTC Probiotics Supplement Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia OTC Probiotics Supplement Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia OTC Probiotics Supplement Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel OTC Probiotics Supplement Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel OTC Probiotics Supplement Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel OTC Probiotics Supplement Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE OTC Probiotics Supplement Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE OTC Probiotics Supplement Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE OTC Probiotics Supplement Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey OTC Probiotics Supplement Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey OTC Probiotics Supplement Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey OTC Probiotics Supplement Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran OTC Probiotics Supplement Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran OTC Probiotics Supplement Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran OTC Probiotics Supplement Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt OTC Probiotics Supplement Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt OTC Probiotics Supplement Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt OTC Probiotics Supplement Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Danone
  2. 8.1.1 Danone Company Information
  3. 8.1.2 Danone Business Overview
  4. 8.1.3 Danone OTC Probiotics Supplement Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Danone OTC Probiotics Supplement Product Portfolio
  6. 8.1.5 Danone Recent Developments
  7. 8.2 Dietary Pros, Inc.
  8. 8.2.1 Dietary Pros, Inc. Company Information
  9. 8.2.2 Dietary Pros, Inc. Business Overview
  10. 8.2.3 Dietary Pros, Inc. OTC Probiotics Supplement Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Dietary Pros, Inc. OTC Probiotics Supplement Product Portfolio
  12. 8.2.5 Dietary Pros, Inc. Recent Developments
  13. 8.3 DuPont
  14. 8.3.1 DuPont Company Information
  15. 8.3.2 DuPont Business Overview
  16. 8.3.3 DuPont OTC Probiotics Supplement Revenue and Gross Margin (2021-2026)
  17. 8.3.4 DuPont OTC Probiotics Supplement Product Portfolio
  18. 8.3.5 DuPont Recent Developments
  19. 8.4 Kibow Biotech
  20. 8.4.1 Kibow Biotech Company Information
  21. 8.4.2 Kibow Biotech Business Overview
  22. 8.4.3 Kibow Biotech OTC Probiotics Supplement Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Kibow Biotech OTC Probiotics Supplement Product Portfolio
  24. 8.4.5 Kibow Biotech Recent Developments
  25. 8.5 Lifeway Foods, Inc.
  26. 8.5.1 Lifeway Foods, Inc. Company Information
  27. 8.5.2 Lifeway Foods, Inc. Business Overview
  28. 8.5.3 Lifeway Foods, Inc. OTC Probiotics Supplement Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Lifeway Foods, Inc. OTC Probiotics Supplement Product Portfolio
  30. 8.5.5 Lifeway Foods, Inc. Recent Developments
  31. 8.6 Osmotica Pharmaceuticals Corp
  32. 8.6.1 Osmotica Pharmaceuticals Corp Company Information
  33. 8.6.2 Osmotica Pharmaceuticals Corp Business Overview
  34. 8.6.3 Osmotica Pharmaceuticals Corp OTC Probiotics Supplement Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Osmotica Pharmaceuticals Corp OTC Probiotics Supplement Product Portfolio
  36. 8.6.5 Osmotica Pharmaceuticals Corp Recent Developments
  37. 8.7 Pharmavite LLC
  38. 8.7.1 Pharmavite LLC Company Information
  39. 8.7.2 Pharmavite LLC Business Overview
  40. 8.7.3 Pharmavite LLC OTC Probiotics Supplement Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Pharmavite LLC OTC Probiotics Supplement Product Portfolio
  42. 8.7.5 Pharmavite LLC Recent Developments
  43. 8.8 Probi AB
  44. 8.8.1 Probi AB Company Information
  45. 8.8.2 Probi AB Business Overview
  46. 8.8.3 Probi AB OTC Probiotics Supplement Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Probi AB OTC Probiotics Supplement Product Portfolio
  48. 8.8.5 Probi AB Recent Developments
  49. 8.9 Royal DSM
  50. 8.9.1 Royal DSM Company Information
  51. 8.9.2 Royal DSM Business Overview
  52. 8.9.3 Royal DSM OTC Probiotics Supplement Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Royal DSM OTC Probiotics Supplement Product Portfolio
  54. 8.9.5 Royal DSM Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst